Want to see IN:PGHL full AI Analyst Report?
Procter & Gamble Health Ltd. (PGHL) Ratios
Procter & Gamble Health Ltd. Ratios
IN:PGHL's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:PGHL's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.18 | 2.44 | 2.39 | 2.62 | 2.60 |
| Quick Ratio | 1.65 | 1.94 | 1.90 | 2.18 | 2.11 |
| Cash Ratio | 0.73 | 0.88 | 1.12 | 1.43 | 1.35 |
| Solvency Ratio | 1.11 | 1.05 | 0.88 | 0.72 | 0.77 |
| Operating Cash Flow Ratio | 1.33 | 0.82 | 1.04 | 0.78 | 0.72 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 62.58 | 0.00 | 9.05 | 0.00 |
| Net Current Asset Value | $ 2.39B | $ 2.69B | $ 2.68B | $ 4.46B | $ 3.36B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Debt-to-Equity Ratio | 0.02 | 0.01 | 0.02 | 0.02 | 0.00 |
| Debt-to-Capital Ratio | 0.02 | 0.01 | 0.02 | 0.02 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.60 | 1.48 | 1.48 | 1.47 | 1.45 |
| Debt Service Coverage Ratio | 638.27 | 82.41 | 320.93 | 8.72 | 485.52 |
| Interest Coverage Ratio | 787.40 | 1104.43 | 745.39 | 726.51 | 1136.12 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 5.93 | 4.94 | 6.19 | 7.68 | 1.96 |
| Net Debt to EBITDA | -0.37 | -0.50 | -0.77 | -1.33 | -1.20 |
| Profitability Margins | |||||
| Gross Profit Margin | 56.59% | 71.35% | 70.25% | 68.82% | 68.32% |
| EBIT Margin | 31.99% | 28.17% | 24.24% | 24.06% | 21.77% |
| EBITDA Margin | 33.67% | 29.73% | 26.35% | 25.92% | 23.76% |
| Operating Profit Margin | 30.76% | 51.98% | 46.62% | 45.49% | 42.82% |
| Pretax Profit Margin | 31.95% | 27.46% | 23.74% | 25.55% | 22.74% |
| Net Profit Margin | 23.22% | 20.62% | 17.46% | 18.66% | 17.28% |
| Continuous Operations Profit Margin | 23.22% | 20.62% | 17.46% | 18.66% | 17.28% |
| Net Income Per EBT | 72.67% | 75.11% | 73.53% | 73.03% | 75.98% |
| EBT Per EBIT | 103.88% | 52.82% | 50.93% | 56.17% | 53.10% |
| Return on Assets (ROA) | 38.86% | 31.63% | 25.30% | 20.84% | 21.54% |
| Return on Equity (ROE) | 62.32% | 46.78% | 37.34% | 30.56% | 31.23% |
| Return on Capital Employed (ROCE) | 73.85% | 109.38% | 93.26% | 70.16% | 72.53% |
| Return on Invested Capital (ROIC) | 53.34% | 81.75% | 68.26% | 49.43% | 54.88% |
| Return on Tangible Assets | 38.88% | 31.66% | 25.33% | 20.86% | 21.54% |
| Earnings Yield | 4.10% | 2.94% | 2.37% | 2.63% | 2.77% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.46 | 8.29 | 11.46 | 10.63 | 12.04 |
| Payables Turnover | 3.18 | 2.03 | 2.05 | 1.62 | 2.05 |
| Inventory Turnover | 4.47 | 3.19 | 3.14 | 2.84 | 3.06 |
| Fixed Asset Turnover | 12.48 | 9.98 | 8.75 | 7.10 | 7.45 |
| Asset Turnover | 1.67 | 1.53 | 1.45 | 1.12 | 1.25 |
| Working Capital Turnover Ratio | 4.60 | 3.95 | 2.89 | 2.83 | 2.57 |
| Cash Conversion Cycle | 9.97 | -21.04 | -29.85 | -62.86 | -28.47 |
| Days of Sales Outstanding | 43.12 | 44.05 | 31.84 | 34.35 | 30.32 |
| Days of Inventory Outstanding | 81.60 | 114.39 | 116.26 | 128.47 | 119.11 |
| Days of Payables Outstanding | 114.76 | 179.48 | 177.95 | 225.68 | 177.90 |
| Operating Cycle | 124.73 | 158.44 | 148.10 | 162.82 | 149.43 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 203.50 | 105.93 | 137.44 | 141.93 | 102.13 |
| Free Cash Flow Per Share | 194.16 | 100.78 | 124.36 | 116.38 | 79.28 |
| Dividend Paid and CapEx Coverage Ratio | 0.95 | 0.73 | 0.52 | 1.73 | 0.53 |
| Capital Expenditure Coverage Ratio | 21.78 | 20.54 | 10.51 | 5.56 | 4.47 |
| Operating Cash Flow Coverage Ratio | 36.36 | 23.08 | 23.88 | 19.67 | 59.90 |
| Operating Cash Flow to Sales Ratio | 0.24 | 0.14 | 0.20 | 0.19 | 0.15 |
| Free Cash Flow Yield | 4.05% | 1.95% | 2.43% | 2.21% | 1.89% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 24.37 | 34.11 | 42.22 | 38.08 | 36.13 |
| Price-to-Sales (P/S) Ratio | 5.66 | 7.02 | 7.37 | 7.11 | 6.24 |
| Price-to-Book (P/B) Ratio | 15.19 | 15.94 | 15.77 | 11.64 | 11.28 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 24.72 | 51.15 | 41.08 | 45.15 | 52.86 |
| Price-to-Operating Cash Flow Ratio | 23.58 | 48.66 | 37.17 | 37.02 | 41.04 |
| Price-to-Earnings Growth (PEG) Ratio | 0.80 | 1.37 | -3.40 | 1.98 | 4.06 |
| Enterprise Value Multiple | 16.43 | 23.13 | 27.19 | 26.09 | 25.08 |
| Enterprise Value | 77.90B | 83.76B | 82.51B | 83.15B | 66.40B |
| EV to EBITDA | 16.43 | 23.13 | 27.19 | 26.09 | 25.08 |
| EV to Sales | 5.53 | 6.88 | 7.17 | 6.76 | 5.96 |
| EV to Free Cash Flow | 24.17 | 50.07 | 39.95 | 42.97 | 50.45 |
| EV to Operating Cash Flow | 23.06 | 47.63 | 36.15 | 35.23 | 39.17 |
| Tangible Book Value Per Share | 315.73 | 323.06 | 323.47 | 451.01 | 371.38 |
| Shareholders’ Equity Per Share | 316.01 | 323.49 | 324.05 | 451.57 | 371.40 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.27 | 0.25 | 0.26 | 0.27 | 0.24 |
| Revenue Per Share | 848.23 | 733.81 | 693.12 | 739.48 | 671.37 |
| Net Income Per Share | 196.95 | 151.33 | 121.00 | 138.00 | 115.98 |
| Tax Burden | 0.73 | 0.75 | 0.74 | 0.73 | 0.76 |
| Interest Burden | 1.00 | 0.97 | 0.98 | 1.06 | 1.04 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| SG&A to Revenue | 0.00 | 0.19 | 0.19 | 0.17 | 0.15 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Income Quality | 0.75 | 0.56 | 1.14 | 0.75 | 0.67 |
Currency in INR
